Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.

Olsson P, Bodewes ILA, Nilsson AM, Turesson C, Jacobsson LTH, Theander E, Versnel MA, Mandl T.

Rheumatol Int. 2019 Sep;39(9):1575-1584. doi: 10.1007/s00296-019-04335-3. Epub 2019 May 28.

PMID:
31139950
2.

Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.

Mofors J, Holmqvist M, Westermark L, Björk A, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Theander E, Mandl T, Wahren-Herlenius M, Nordmark G.

J Intern Med. 2019 Oct;286(4):458-468. doi: 10.1111/joim.12941. Epub 2019 Jun 17.

PMID:
31127862
3.

Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.

Sternbæk L, Draborg AH, Østerlund MT, Iversen LV, Troelsen L, Theander E, Nielsen CT, Jacobsen S, Houen G.

Scand J Clin Lab Invest. 2019 Feb - Apr;79(1-2):7-16. doi: 10.1080/00365513.2018.1550807. Epub 2019 Feb 6.

PMID:
30727744
4.

Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome.

Vasaitis L, Nordmark G, Theander E, Backlin C, Smedby KE, Askling J, Rönnblom L, Sundström C, Baecklund E.

Scand J Rheumatol. 2019 May;48(3):207-212. doi: 10.1080/03009742.2018.1523456. Epub 2018 Nov 13.

PMID:
30422723
5.

Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients.

Aldridge J, Pandya JM, Meurs L, Andersson K, Nordström I, Theander E, Lundell AC, Rudin A.

Arthritis Res Ther. 2018 Jul 20;20(1):150. doi: 10.1186/s13075-018-1648-2.

6.

Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren's syndrome.

Olsson P, Skogstrand K, Nilsson A, Turesson C, Jacobsson LTH, Theander E, Houen G, Mandl T.

Rheumatol Int. 2018 Aug;38(8):1503-1510. doi: 10.1007/s00296-018-4063-8. Epub 2018 May 30.

7.

Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis.

Trier NH, Holm BE, Heiden J, Slot O, Locht H, Lindegaard H, Svendsen A, Nielsen CT, Jacobsen S, Theander E, Houen G.

Sci Rep. 2018 Feb 27;8(1):3684. doi: 10.1038/s41598-018-22058-6.

8.

The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.

Trier NH, Holm BE, Heiden J, Slot O, Locht H, Jensen B, Lindegaard H, Svendsen A, Nielsen CT, Jacobsen S, Theander E, Houen G.

J Immunol Methods. 2018 Mar;454:6-14. doi: 10.1016/j.jim.2017.11.004. Epub 2017 Nov 8.

PMID:
29128424
9.

Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliability.

Jousse-Joulin S, Nowak E, Cornec D, Brown J, Carr A, Carotti M, Fisher B, Fradin J, Hocevar A, Jonsson MV, Luciano N, Milic V, Rout J, Theander E, Stel A, Bootsma H, Vissink A, Baldini C, Baer A, Ng WF, Bowman S, Alavi Z, Saraux A, Devauchelle-Pensec V.

RMD Open. 2017 Jun 9;3(1):e000364. doi: 10.1136/rmdopen-2016-000364. eCollection 2017.

10.

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, Hammenfors D, Jonsson MV, Skarstein K, Brun JG; DISSECT consortium, Rönnblom L, Forsblad-d'Elia H, Magnusson Bucher S, Baecklund E, Theander E, Omdal R, Jonsson R, Nordmark G, Wahren-Herlenius M.

Biol Sex Differ. 2017 Aug 8;8(1):25. doi: 10.1186/s13293-017-0146-6.

11.

DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort.

Lindqvist U, Wernroth ML, Husmark T, Larsson P, Geijer M, Teleman A, Theander E, Alenius GM.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):936-942. Epub 2017 Jun 16.

PMID:
28628468
12.

Income disparities in healthcare use remain after controlling for healthcare need: evidence from Swedish register data on psoriasis and psoriatic arthritis.

Löfvendahl S, Jöud A, Petersson IF, Theander E, Svensson Å, Carlsson KS.

Eur J Health Econ. 2018 Apr;19(3):447-462. doi: 10.1007/s10198-017-0895-5. Epub 2017 May 19.

13.

Cigarette smoking and the risk of primary Sjögren's syndrome: a nested case control study.

Olsson P, Turesson C, Mandl T, Jacobsson L, Theander E.

Arthritis Res Ther. 2017 Mar 7;19(1):50. doi: 10.1186/s13075-017-1255-7.

14.

Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.

Pandya JM, Lundell AC, Andersson K, Nordström I, Theander E, Rudin A.

Arthritis Res Ther. 2017 Feb 2;19(1):20. doi: 10.1186/s13075-017-1224-1.

15.

Efficient evaluation of humoral immune responses by the use of serum pools.

Sternbæk L, Draborg AH, Nielsen CT, Jacobsen S, Iversen LV, Troelsen L, Theander E, Houen G.

J Immunol Methods. 2017 Apr;443:1-8. doi: 10.1016/j.jim.2017.01.006. Epub 2017 Jan 25.

PMID:
28130033
16.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, Kvarnstrom M, Sene D, Gerli R, Praprotnik S, Isenberg D, Solans R, Rischmueller M, Kwok SK, Nordmark G, Suzuki Y, Giacomelli R, Devauchelle-Pensec V, Bombardieri M, Hofauer B, Bootsma H, Brun JG, Fraile G, Carsons SE, Gheita TA, Morel J, Vollenveider C, Atzeni F, Retamozo S, Horvath IF, Sivils K, Mandl T, Sandhya P, De Vita S, Sanchez-Guerrero J, van der Heijden E, Trevisani VFM, Wahren-Herlenius M, Mariette X, Ramos-Casals M; EULAR-SS Task Force Big Data Consortium.

Ann Rheum Dis. 2017 Jun;76(6):1042-1050. doi: 10.1136/annrheumdis-2016-209952. Epub 2016 Nov 29.

PMID:
27899373
17.

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.

Bengtsson AA, Trygg J, Wuttge DM, Sturfelt G, Theander E, Donten M, Moritz T, Sennbro CJ, Torell F, Lood C, Surowiec I, Rännar S, Lundstedt T.

PLoS One. 2016 Jul 21;11(7):e0159384. doi: 10.1371/journal.pone.0159384. eCollection 2016.

18.

Sjögren syndrome.

Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M.

Nat Rev Dis Primers. 2016 Jul 7;2:16047. doi: 10.1038/nrdp.2016.47. Review.

PMID:
27383445
19.

Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity.

Olsson P, Theander E, Bergström U, Jovinge S, Jacobsson L, Turesson C.

Scand J Rheumatol. 2017 Jan;46(1):1-10. doi: 10.3109/03009742.2016.1161070. Epub 2016 May 12.

PMID:
27172254
20.

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies.

Seror R, Meiners P, Baron G, Bootsma H, Bowman SJ, Vitali C, Gottenberg JE, Theander E, Tzioufas A, De Vita S, Ramos-Casals M, Dörner T, Quartuccio L, Ravaud P, Mariette X; EULAR Sjögren Task Force.

Ann Rheum Dis. 2016 Nov;75(11):1945-1950. doi: 10.1136/annrheumdis-2015-208504. Epub 2016 Jan 25.

PMID:
27150113
21.

Reply.

Jonsson R, Henriksson G, Theander E.

Arthritis Rheumatol. 2016 Aug;68(8):2055-6. doi: 10.1002/art.39702. No abstract available.

22.

Comparison of antibody assays for detection of autoantibodies to Ro 52, Ro 60 and La associated with primary Sjögren's syndrome.

Trier NH, Nielsen IØ, Friis T, Houen G, Theander E.

J Immunol Methods. 2016 Jun;433:44-50. doi: 10.1016/j.jim.2016.03.001. Epub 2016 Mar 6.

PMID:
26956184
23.

Application of synthetic peptides for detection of anti-citrullinated peptide antibodies.

Trier NH, Holm BE, Slot O, Locht H, Lindegaard H, Svendsen A, Nielsen CT, Jacobsen S, Theander E, Houen G.

Peptides. 2016 Feb;76:87-95. doi: 10.1016/j.peptides.2016.01.005. Epub 2016 Jan 12.

PMID:
26796582
24.

Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?

Löfvendahl S, Petersson IF, Theander E, Svensson Å, Zhou C, Steen Carlsson K.

J Rheumatol. 2016 Mar;43(3):640-7. doi: 10.3899/jrheum.150406. Epub 2016 Jan 15.

PMID:
26773111
25.

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.

Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Bombardieri S, de Vita S, Mandl T, Ng WF, Kruize AA, Tzioufas A, Vitali C, Buyon J, Izmirly P, Fox R, Ramos-Casals M; Eular Sjögren Syndrome Task Force.

Expert Rev Clin Immunol. 2016;12(2):137-56. doi: 10.1586/1744666X.2016.1109449. Epub 2015 Dec 22. Review. Erratum in: Expert Rev Clin Immunol. 2017 May;13(5):507.

PMID:
26691952
26.

Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review.

Jousse-Joulin S, Milic V, Jonsson MV, Plagou A, Theander E, Luciano N, Rachele P, Baldini C, Bootsma H, Vissink A, Hocevar A, De Vita S, Tzioufas AG, Alavi Z, Bowman SJ, Devauchelle-Pensec V; US-pSS Study Group.

Rheumatology (Oxford). 2016 May;55(5):789-800. doi: 10.1093/rheumatology/kev385. Epub 2015 Dec 14. Review.

PMID:
26667216
27.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

28.

The Swedish Early Psoriatic Arthritis Registry 5-year Followup: Substantial Radiographic Progression Mainly in Men with High Disease Activity and Development of Dactylitis.

Geijer M, Lindqvist U, Husmark T, Alenius GM, Larsson PT, Teleman A, Theander E.

J Rheumatol. 2015 Nov;42(11):2110-7. doi: 10.3899/jrheum.150165. Epub 2015 Oct 15.

PMID:
26472410
29.

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.

Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Theander E, Bombardieri S, De Vita S, Mandl T, Ng WF, Kruize A, Tzioufas A, Vitali C; EULAR Sjögren Syndrome Task Force.

Rheumatology (Oxford). 2015 Dec;54(12):2230-8. doi: 10.1093/rheumatology/kev200. Epub 2015 Jul 31. Erratum in: Rheumatology (Oxford). 2017 Jul 1;56(7):1245.

30.

Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.

Theander E, Jonsson R, Sjöström B, Brokstad K, Olsson P, Henriksson G.

Arthritis Rheumatol. 2015 Sep;67(9):2427-36. doi: 10.1002/art.39214.

31.

Chronic obstructive pulmonary disease is common in never-smoking patients with primary Sjögren syndrome.

Nilsson AM, Diaz S, Theander E, Hesselstrand R, Piitulainen E, Ekberg O, Wollmer P, Mandl T.

J Rheumatol. 2015 Mar;42(3):464-71. doi: 10.3899/jrheum.140370. Epub 2015 Jan 15.

PMID:
25593235
32.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5.

PMID:
25480887
33.

Quality of Life in Patients With Axial Spondyloarthritis in Clinical Practice In Sweden: Baseline Results From A Longitudinal Study.

Jacobsson LT, Husmark T, Theander E, Henriksson K, Johansson M, Büsch K.

Value Health. 2014 Nov;17(7):A386. doi: 10.1016/j.jval.2014.08.2648. Epub 2014 Oct 26. No abstract available.

34.

Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study.

Löfvendahl S, Theander E, Svensson Å, Carlsson KS, Englund M, Petersson IF.

PLoS One. 2014 May 29;9(5):e98024. doi: 10.1371/journal.pone.0098024. eCollection 2014.

35.

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).

Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, Bootsma H, Tzioufas A, Solans-Laqué R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Valesini G, Bartoloni E, Saraux A, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2015 May;74(5):859-66. doi: 10.1136/annrheumdis-2013-204615. Epub 2014 Jan 17.

PMID:
24442883
36.

Outcome measures for primary Sjögren's syndrome: a comprehensive review.

Seror R, Theander E, Bootsma H, Bowman SJ, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Mariette X, Vitali C.

J Autoimmun. 2014 Jun;51:51-6. doi: 10.1016/j.jaut.2013.12.010. Epub 2014 Jan 8. Review.

PMID:
24411404
37.

The forced oscillation technique is a sensitive method for detecting obstructive airway disease in patients with primary Sjögren's syndrome.

Nilsson AM, Theander E, Hesselstrand R, Piitulainen E, Wollmer P, Mandl T.

Scand J Rheumatol. 2014;43(4):324-8. doi: 10.3109/03009742.2013.856466. Epub 2014 Jan 7.

PMID:
24392743
38.

Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system.

Theander E, Mandl T.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):1102-7. doi: 10.1002/acr.22264.

39.

Autoantibodies present before symptom onset in primary Sjögren syndrome.

Jonsson R, Theander E, Sjöström B, Brokstad K, Henriksson G.

JAMA. 2013 Nov 6;310(17):1854-5. doi: 10.1001/jama.2013.278448. No abstract available.

PMID:
24193084
40.

Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.

Nordmark G, Wang C, Vasaitis L, Eriksson P, Theander E, Kvarnström M, Forsblad-d'Elia H, Jazebi H, Sjöwall C, Reksten TR, Brun JG, Jonsson MV, Johnsen SJ, Wahren-Herlenius M, Omdal R, Jonsson R, Bowman S, Ng WF, Eloranta ML, Syvänen AC; UK Primary Sjögren’s Syndrome Registry.

Scand J Immunol. 2013 Nov;78(5):447-54. doi: 10.1111/sji.12101.

41.

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.

Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, Forsblad-d'Elia H, Omdal R, Wahren-Herlenius M, Jonsson R, Rönnblom L, Nititham J, Taylor KE, Lessard CJ, Sivils KL, Gottenberg JE, Criswell LA, Miceli-Richard C, Zitvogel L, Mariette X.

Sci Transl Med. 2013 Jul 24;5(195):195ra96. doi: 10.1126/scitranslmed.3005727.

42.

Genetic associations to germinal centre formation in primary Sjogren's syndrome.

Reksten TR, Johnsen SJ, Jonsson MV, Omdal R, Brun JG, Theander E, Eriksson P, Wahren-Herlenius M, Jonsson R, Nordmark G.

Ann Rheum Dis. 2014 Jun;73(6):1253-8. doi: 10.1136/annrheumdis-2012-202500. Epub 2013 Apr 20.

PMID:
23606706
43.

No association of primary Sjögren's syndrome with Fcγ receptor gene variants.

Haldorsen K, Appel S, Le Hellard S, Bruland O, Brun JG, Omdal R, Kristjansdottir G, Theander E, Fernandes CP, Kvarnström M, Eriksson P, Rönnblom L, Herlenius MW, Nordmark G, Jonsson R, Bolstad AI.

Genes Immun. 2013 Jun;14(4):234-7. doi: 10.1038/gene.2013.12. Epub 2013 Apr 4.

PMID:
23552400
44.

Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).

Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, Lindqvist UR.

Ann Rheum Dis. 2014 Feb;73(2):407-13. doi: 10.1136/annrheumdis-2012-201972. Epub 2013 Jan 25.

PMID:
23355078
45.

Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue.

Vitali C, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Seror R, Theander E, Tzioufas AG.

Ann Rheum Dis. 2013 Apr;72(4):476-8. doi: 10.1136/annrheumdis-2012-202565. Epub 2012 Dec 22.

PMID:
23264355
46.

Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome.

Jonsson MV, Theander E, Jonsson R.

Presse Med. 2012 Sep;41(9 Pt 2):e511-6. doi: 10.1016/j.lpm.2012.05.025. Epub 2012 Aug 3. Review.

PMID:
22867948
47.

Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.

Draborg AH, Jørgensen JM, Müller H, Nielsen CT, Jacobsen S, Iversen LV, Theander E, Nielsen LP, Houen G, Duus K.

Scand J Rheumatol. 2012 Aug;41(4):280-9. doi: 10.3109/03009742.2012.665944. Epub 2012 May 31.

PMID:
22646970
48.

Outcome measures for primary Sjögren's syndrome.

Seror R, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Theander E, Tzioufas A, Vitali C.

J Autoimmun. 2012 Aug;39(1-2):97-102. doi: 10.1016/j.jaut.2012.01.013. Epub 2012 Feb 24. Review.

PMID:
22365784
49.

Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples.

Bolstad AI, Le Hellard S, Kristjansdottir G, Vasaitis L, Kvarnström M, Sjöwall C, Johnsen SJ, Eriksson P, Omdal R, Brun JG, Wahren-Herlenius M, Theander E, Syvänen AC, Rönnblom L, Nordmark G, Jonsson R.

Ann Rheum Dis. 2012 Jun;71(6):981-8. doi: 10.1136/annrheumdis-2011-200446. Epub 2012 Jan 30.

PMID:
22294627
50.

Frequent development of chronic obstructive pulmonary disease in primary SS--results of a longitudinal follow-up.

Mandl T, Diaz S, Ekberg O, Hesselstrand R, Piitulainen E, Wollmer P, Theander E.

Rheumatology (Oxford). 2012 May;51(5):941-6. doi: 10.1093/rheumatology/ker409. Epub 2012 Jan 17.

PMID:
22258389

Supplemental Content

Loading ...
Support Center